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Expression and Function of the LIM Homeobox
Containing Genes Lhx3 and Lhx4 in the Mouse
Placenta
Geng Tian,1† Umashankar Singh,1† Yang Yu,1† Buffy S. Ellsworth,2 Myriam Hemberger,3
Rudolf Geyer,4 M. David Stewart,5 Richard R. Behringer,5 and Reinald Fundele1*
The LIM homeobox containing genes of the LIM-3 group, Lhx3 and Lhx4, are critical for normal
development. Both genes are involved in the formation of the pituitary and the motoneuron system and loss
of either gene causes perinatal lethality. Previous studies had shown that Lhx3 is overexpressed in
hyperplastic placentas of mouse interspecies hybrids. To determine the role of LHX3 in the mouse placenta,
we performed expression and function analyses. Our results show that Lhx3 exhibits specific spatial and
temporal expression in the mouse placenta. However, deletion of Lhx3 does not produce a placental
phenotype. To test whether this is due to functional substitution by Lhx4, we performed a phenotype
analysis of Lhx3/; Lhx4/ double-mutant placentas. A subset of Lhx3/; Lhx4/ placentas exhibited
abnormal structure of the labyrinth. However, absence of both LIM-3 genes did not interfere with placental
transport nor consistently with expression of target genes such as Gnrhr. Thus, LHX3 and LHX4 appear to
be dispensable for placental development and function. Developmental Dynamics 237:1517–1525, 2008.
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INTRODUCTION
A functional placenta is an absolute
prerequisite for development to term
in all eutherian mammals, including
man, and defects that severely com-
promise placental function will result
in fetal lethality (Rossant and Cross,
2001; Cross et al., 2003). Significantly
impaired placental transport function
that does not jeopardize survival of
the developing fetus will still cause
fetal undernutrition and intrauterine
growth restriction (IUGR), which is
again associated with a high incidence
of perinatal lethality (Cross, 2006).
However, even newborns that survive
this critical perinatal period will suf-
fer from late to very late effects of
IUGR on brain development (Lane et
al., 2001), energy metabolism (Sim-
mons et al., 2001; Tsirka et al., 2001),
cardiac function (Gagnon, 2003; Lei-
pala et al., 2003; Vonnahme et al.,
2003; Xu et al., 2006), and other organ
systems (Vonnahme et al., 2003).
These findings stress the pivotal role
of the placenta in normal fetal devel-
opment. In recent years, numerous
genes have been identified in the
mouse that, when mutated, cause ab-
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normal placental phenotypes. This
clearly demonstrates that these genes
are important in normal placentation
(Rossant and Cross, 2001; Hemberger
and Cross, 2001; Cross et al., 2003).
However, the functional roles of many
other genes expressed in the placenta
have not been revealed to date.
We had previously reported global
mRNA expression profiles of murine
hyperplastic placentas (Singh et al.,
2004) generated by interspecific hy-
bridization between different mouse
species (interspecies hybrid placental
dysplasia; IHPD) (Zechner et al.,
1996, 2002), reproductive cloning
(Tanaka et al., 2001), and mutation of
the X-linked gene Esx1 (Li and Be-
hringer, 1998). In that study, we had
identified a considerable number of
genes that are differentially expressed
between normal and hyperplastic pla-
centas, thus forming a pool of poten-
tial placentation genes. Altered ex-
pression of some of these genes could
reflect secondary changes due to dis-
turbed gene expression cascades or
shifts in tissue proportions. Indeed,
deletion of some genes identified in
our previous study (Singh et al., 2004)
did not cause any placental pheno-
types (Singh et al., 2005, 2006a). On
the other hand, deletion of other such
genes was associated with placental
phenotypes, thus providing evidence
for their functional roles in placental
development (Singh et al., 2006b,
2007). Thus, analysis of more genes
from this set of data is likely to in-
crease our knowledge about gene func-
tion in mouse placentation.
A gene that was shown to be upregu-
lated in hyperplastic IHPD placentas,
Lhx3, encodes a LIM homeodomain
transcription factor (Singh et al., 2004).
Together with Lhx4, Lhx3 forms the
LIM-3 group within the LIM homeobox
gene family, which is characterized by a
conserved homeodomain that it is dis-
tinctive from that of other homeodo-
main-containing families (Hobert and
Westphal, 2000). As shown by gene tar-
geting in the mouse, the LIM-3 group
genes are important in pituitary and
motor neuron development (Sheng et
al., 1996, 1997; Sharma et al., 1998;
Mullen et al., 2007; Raetzman et al.,
2002; Ellsworth et al., 2008). Interest-
ingly, Lhx3 and Lhx4 have both redun-
dant and complementary functions in
these developmental processes (Sheng
et al., 1997; Sharma et al., 1998). Thus,
formation of the definite Rathke’s pouch
is controlled in a redundant manner by
both Lhx3 and Lhx4 as shown by the
analysis of Lhx3/; Lhx4/ mouse
embryos. However, the presence of one
wild-type allele, such as in Lhx3/;
Lhx4/ or Lhx3/; Lhx4/ is suf-
ficient for formation of a definitive
pouch (Sheng et al., 1997). For the next
developmental step, formation of a
proper pituitary structure and specifi-
cation of pituitary lineages, Lhx3 ex-
pression is an absolute requirement
(Sheng et al., 1997). Thus, the presence
of one Lhx3 wild-type allele is sufficient
for pituitary development, but Lhx4
wild-type alleles are not able to substi-
tute for Lhx3 (Sheng et al., 1997). In a
subsequent step, both Lhx3 and Lhx4
together control proliferation and differ-
entiation of pituitary-specific cell lin-
eages (Sheng et al., 1997). In contrast to
this, during the differentiation of motor
neurons Lhx3 and Lhx4 act in a plain
redundant manner, that is, either Lhx3
or Lhx4 alone are competent to specify
motor neuron identity (Sharma et al.,
1998).
Up-regulation of Lhx3 in abnormal
placentation raised the possibility that
this transcription factor could be impor-
tant in placental development. To test
this possibility, we performed Lhx3 in
situ hybridization to characterize the
spatio-temporal expression pattern of
this gene. We furthermore analyzed
Lhx3 placentas and, when these failed
to exhibit any obvious phenotypes,
Lhx3; Lhx4 double mutant placentas.
Unexpectedly, even though Lhx3 and
Lhx4 are both expressed in the spongio-
trophoblasts, double-homozygous mu-
tant placentas exhibited a specific but
not fully penetrant phenotype charac-
terized by defective labyrinth structure.
This finding suggests that other, to date
unidentified, genes can substitute for
both LIM-3 transcription factors in




of Lhx3 and Lhx4 mRNA in
the Placenta
Lhx3 expression was assayed on E8,
E10, E12, E14, and E18 wild type pla-
centas. No expression of Lhx3 was de-
tected at E8 (Fig. 1A). At E10, the
expression was in the ectoplacental
cone and the developing spongiotro-
phoblast (Fig. 1B, arrow). From E12
onwards, the expression was predom-
inantly in parts of the spongiotropho-
blast (Fig. 1C, arrow) and in many
small foci in the labyrinth (see Supple-
mental Fig. 1, which can be viewed at
www.interscience.wiley.com/jpages/
1058-8388/suppmat). Use of several
markers for placental cell types, such
as Tpbpa, Prl3d1, Prl3b1, Eomes, and
Tfeb, did not allow identification of the
cell types present in these foci. Similar
expression was seen at E14 and E16
(Fig. 1D, E, arrows). Between E12 and
E16, only a limited overlap in the spa-
tial expression patterns of Tpbpa and
Lhx3 could be observed, showing that
not all spongiotrophoblasts expressed
Lhx3 (Fig. 1E–L). At E14 and E16,
weak expression was seen in the gly-
cogen cells situated in the decidua (ar-
rows in Fig. 1E,F). Lhx3 expression
declined after E16 and extremely
weak expression was detected in the
spongiotrophoblast of E18 placentas
(Fig. 1F). Decidua glycogen cells, how-
ever, expressed Lhx3 at comparable
levels in E16 and E18 placentas (ar-
rows in Fig. 1F and E). Expression
was not observed in giant cells and in
the glycogen cells present in spongio-
trophoblast or labyrinth.
Lhx4 in situ hybridization was car-
ried out only on E18 wild type placen-
tas. Lhx4 expression was detected
specifically in the spongiotrophoblast
region (Fig. 1N). Temporal expression
pattern of both Lhx3 and Lhx4 was
determined by RT-PCR. In contrast to
the Lhx3 in situ analysis, RT-PCR
showed no major changes in expres-
sion levels for both genes between E10
and E10 of gestation. Expression of
other LIM-homeobox genes, Lhx1,
Lhx2, Lhx4, Lhx5, Lhx6, Lhx8, and
Lhx9, was also assessed by RT-PCR
only. By this method, transcripts from
all genes were detected in the E18
mouse placenta (not shown).
Lhx3 Mutation Causes No
Changes in Placental Weight
and Morphology
From the Lhx3 het  het matings,
four litters with a total of 42 E18 con-
ceptuses were obtained. These con-
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sisted of 25 heterozygous (14 females
and 11 males), 10 homozygous mutant
(5 females and 5 males), and 7 wild
type (5 females and 2 males) concep-
tuses. Weights of Lhx3/, Lhx3/,
and Lhx3/ placentas were 88.7 
10.0, 87.4  11.5, and 89.2  13.6 mg,
respectively. Thus there was no con-
sistent effect of the Lhx3 mutation on
the wet placental weight and this ef-
fect was independent of the fetal sex
(not shown).
Isolectin B4-stained sections were
studied for changes in placental mor-
phology. Light microscopy did not re-
veal any significant differences. Fur-
thermore, 2 isolectin B4-stained
sections from 2 placentas of each ge-
notype and sex combination, alto-
gether 24 sections, were analyzed by
semi-quantitative morphometry for
subtle differences in the section-areas
occupied by decidua, spongiotropho-
blast and labyrinth. As with placental
weight, no significant difference was
found between different genotypes
(not shown). Furthermore, in situ hy-
bridization revealed that the spatial
expression patterns of the placental
cell type-specific markers Tpbpa,
Prl3d1, Prl3b1, Eomes, and Tfeb were
not altered in Lhx3 mutant placentas
(not shown). Together these results in-
dicated that loss of LHX3 does not
cause any obvious placental pheno-
types.
Deletion of Both Lhx3 and
Lhx4 Causes an Inconsistent
Labyrinthine Phenotype
As it is known that in pituitary and
motoneuron development, LHX3 and
LHX4 may substitute for each other,
the possibility existed that expression
of Lhx4 could compensate for loss of
LHX3. This possibility was supported
by the similar expression of Lhx3 and
Lhx4 in the mouse placenta. However,
as assessed by RT-PCR, Lhx4 tran-
script levels did not vary between
Lhx3/ and Lhx3/ placentas (not
shown). Thus, Lhx3/; Lhx4/
double het  het matings were per-
formed. A total of 17 E18 litters with
176 conceptuses were obtained and
among these 7 Lhx3/; Lhx4/
conceptuses were identified (4%). No
significant differences in placental
weight were observed between the dif-
ferent genotypes (Table 1). Further-
more, histological analysis of placen-
tas showed no discernible difference
between any of the genotypes, with
the exception of some Lhx3/;
Lhx4/ placentas (see below). This
suggests that the presence of a single
LIM-3 allele, as in Lhx3/;
Lhx4/ or Lhx3/; Lhx4/, is
fully compatible with normal placen-
tal development. However, in three
E18 litters (litter 1, 3, and 5; Suppl.
Table 2), double mutant fetuses were
smaller as compared to other fetuses
in the same litter (Table 1). Compar-
ative histological analysis of isolectin
B4 stained sections from 5 Lhx3/;
Lhx4/ and control placentas from
the same litters showed that 3 double-
mutant placentas exhibited a specific
abnormal phenotype, which did not
correlate with reduced fetal size
(Suppl. Table 2). This phenotype was
characterized by loose organization of
labyrinthine architecture, with re-
duced density of isolectin B4-positive
trophoblast basement membranes
(Fig. 2A–F). This finding was sup-
ported by ASMA staining, which re-
vealed a similar disorganization of
pericytes in the 3 abnormal Lhx3/;
Lhx4/ placentas (Fig. 2G,H). Peri-
Fig. 1. In situ expression analysis of Lhx3 and Lhx4. A: E8 conceptus shows no expression of
Lhx3. B: At E10, the expression is seen in the ectoplacetal cone and the invasive trophoblasts
(arrow), whereas the embryo is devoid of any expression. C: In E12 placentas, predominant
expression is detected in many parts of spongiotrophoblast (arrow) and multiple foci in the
labyrinth. Expression in the rare patches of the decidua is not clearly seen at this magnification. D:
A similar expression pattern is seen in E14 placentas, but expression is reduced in spongiotro-
phoblast and increased in the decidua (arrow). E: At E16, decidual expression is even stronger
(arrows), but further reduced in spongiotrophoblast and in the labyrinth (arrowhead). F: Finally at
E18, weak expression is seen only in the decidua (arrows) with no expression in spongiotrophoblast
(arrowhead), which earlier was a major site for Lhx3 expression. Overviews of Tpbpa expression on
sections adjacent to those shown in E and F show that Lhx3 is expressed only in a subset of
spongiotrophoblasts at E16 and confirms that it is not expressed in this tissue at E18. I,J: Higher
magnification views of Lhx3 and Tpbpa hybridizations on adjacent sections of an E12 placenta
show that in some parts of the spongiotrophoblast expression is spatially separated, whereas in
other nearby parts they overlap. Decidual expression of Lhx3 in E12 placenta can be seen (J). K,L:
At E18, Lhx3 and Tpbpa are not co-expressed anymore. M: RT-PCR analysis of Lhx3 and Lhx4
expression during placental development. N: Lhx4 expression in E18 placentas, arrows show
positive signal (in spongiotrophoblast). Scale bars  200 m (A,B), 300 m (C), 400 m (D), 500 m
(E–H), 125 m (I, J), 100 m (K, L), 250 m (N).
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cytes function in capillary looping in
the labyrinth (Ohlsson et al., 1999).
However, in the remaining 2 double-
mutant placentas, no difference could
be detected compared to control pla-
centas. Semi-quantitative morpho-
metrical analysis, which was per-
formed on three double mutant and
six control placental sections stained
with isolectin B4, showed no signifi-
cant alterations in placental tissue
distribution.
Normalization of Lhx3 and
Lhx4 Expression Levels Does
Not Rescue the Placental
Phenotypes of AT24 Mice
Like the hyperplastic IHPD placentas,
AT24 placentas over-express Lhx3
(not shown). In order to establish
whether over-expression of LIM-3
group genes is a cause or a conse-
quence of placental over growth in
IHPD, we tested the effect of reduc-
tion of LHX3 and LHX4 levels in AT24
placentas. From 2 E18 AT24/AT24 
Lhx3/; Lhx4/ pregnancies, 18
conceptuses were isolated. Four con-
ceptuses were AT24/; Lhx3/;
Lhx4/ and 3 were AT24/;
Lhx3/; Lhx4/. The remaining
conceptuses were either Lhx3/ or
Lhx4/. Mean placental weights
were 165.8  10.1 mg for AT24/;
Lhx3/; Lhx4/ and 162.5  21.0
mg for AT24/; Lhx3/; Lhx4/.
Thus, reduction of LIM-3 gene expres-
sion by half has no influence on the
AT24 placental phenotype.
Placental Transport
Function Analysis in Lhx3
and Lhx4 Double Mutant
Mice
The abnormal morphology of the laby-
rinth in a sub-set of Lhx3/;
Lhx4/; placentas raised the possibil-
ity that placental transport functions
could be compromised in these
Lhx3/; Lhx4/; placentas. There-
fore, one parameter of placental trans-
port was assessed by determining the
accumulation of the essential fatty ac-
ids (EFAs) linoleic acid (18:2), arachi-
donic acid (20:4), and docosahexaenoic
acid (22:6), and the non-essential fatty
acids (NEFAs) palmytic acid (16:0) and
stearic acid (18:0). EFAs are obtained
through the mother’s diet and are,
therefore, transported to the fetal or-
ganism via the placenta. NEFAs are
synthesized in the fetus. With this ap-
Fig. 2. Morphological analysis of a Lhx3/; Lhx4/and control placentas. A,C,E,G: Control
placentas. B,D,F,H: Lhx3/; Lhx4/ placentas. A,B: Overview of isolectin B4 staining; C–F: isolectin
B4 staining in labyrinth; G,H: ASMA staining. Arrows show positive staining. Scale bar  1 mm.















1 (N  9) 83.9  9.0 89.5 1251.0  67.9 1006.4
2 (N  10) 93.7  10.1 88.1 924.6  52.2 886.4
3 (N  10) 82.6  9.3 76.4 930.7  36.7 754.7
4 (N  6) 124.8  11.7 129.5 882.4  105.5 903.8
5 (N  10) 100.7  15.3 88.1 947.8  70.8 842.3
6 (N  11) 87.4  6.8 90.0 876.7  61.7 813.3
7 (N  10) 111.1  17.6 90.0 743.3  49.2 770.0
aValues are given as means  SD. Average placental and fetal weights do not include the Lhx3/; Lhx4/ weights.
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proach, compromisedplacental trans-
port function is indicated by distorted
ratios of EFAs and NEFAs in favor of
the latter (Wu et al., 2003). Our lipid
measurements provided no evidence for
defective lipid transport function of
Lhx3/; Lhx4/ placentas. Thus, in
control E18 fetuses the EFAs made up
22.0  9.4% (N  6) of all FAs. In
Lhx3/; Lhx4/ fetuses this value
was 21.2  4.4 (N  2; P  0.05). In the
placentas from the same conceptuses,
these values were 23.4  4.9 and 20.6 
11.3%, for control and Lhx3/;
Lhx4/ placentas, respectively (P 
0.05). However, this finding does not
exclude the possibility that other trans-
port systems are affected in Lhx3/;
Lhx4/ placentas.
Expression of Lhx3/Lhx4
Target Genes in Lhx3 and
Lhx4 Double Mutant Mice
One of the known target genes of Lhx3
that is expressed in the placenta is
gonadotropin-releasing hormone re-
ceptor (Gnrhr) (McGillivray et al.,
2005; Granger et al., 2006). To deter-
mine if absence of the LIM-3 tran-
scription factors alters expression of
genes involved in the gonadotrope
pathway, levels of Gnrhr and gonado-
tropin-releasing hormone (Gnrh) were
determined in 4 Lhx3/; Lhx4/
placentas and 10 control litter-mate
placentas (Suppl. Table 2) by qRT-
PCR. Furthermore, expression of Dlx3
was assessed, as the product of this
gene is involved in the regulation of
the subunit gene of chorionic gonado-
tropin (Roberson et al., 2001) and its
deletion causes placental failure,
which is however associated with
down-regulation of Esx1 (Morasso et
al., 1999), a gene shown to be relevant
for labyrinthine morphogenesis (Li
and Behringer, 1998). These experi-
ments provided no indication for dif-
ferential expression of Dlx3 and Gnrh
(not shown) in Lhx3/; Lhx4/
and control placentas. However, for
Gnrhr up-regulation was seen in the
phenotypically normal Lhx3/;
Lhx4/ placentas of 2 litters,
whereas in 2 litters where the
Lhx3/; Lhx4/ placentas were
abnormal, Gnrhr expression was not
modified by genotype (Fig. 3B; Suppl.
Table 2). This finding provided some
indication that Gnrhr could possibly
function in placental development. To
test this possibility, isolectin B4-
stained sections of E18 and E19 Gn-
rhr/ and Gnrhr/ littermate pla-
centas were analyzed. At both
developmental stages, 2 mutant and 2
wild-type placentas were compared.
With this light-microscopy approach,
no phenotypic differences could be ob-
served between Gnrhr/ and Gn-
rhr/ placentas.
DISCUSSION
We had previously identified a large
number of genes, which exhibited
changed expression in the following
models: placental over growth (Singh
et al., 2004), interspecific hybridiza-
tion (Zechner et al., 1996), cloning by
somatic cell nuclear transfer (Tanaka
et al., 2001), and mutation of Esx1 (Li
and Behringer, 1998). For a consider-
able number of these genes, there
were no previous reports that demon-
strated or suggested that they had
functions in placental development.
Therefore, in the present study we ini-
tially focused on one gene, Lhx3,
whose expression was increased in
IHPD placentas, as assessed by mi-
croarray, Northern, and in situ hy-
bridization analyses (Singh et al.,
2004). Our study shows that Lhx3 is
expressed in the mouse placenta in a
cell type–specific manner, in that only
three cell types, spongiotrophoblasts,
decidual glycogen cells, and some cells
in the labyrinth zone, express the
gene. In the spongiotrophoblast
proper, which excludes the glycogen
cells also present in the junctional
zone, not all cells expressed Lhx3.
Similarly, Lhx3 expression in glyco-
gen cells was strictly dependent on
their location. The significance of the
differential Lhx3 expression in these
two cell types is presently not clear.
The function of LHX3 as transcrip-
tion factor and the perinatal lethality
of the Lhx3 deletion suggested that
absence of Lhx3 might also result in
abnormal placental development and
the finding that deletion of Lhx3 alone
was not sufficient to cause any alter-
ations in placental histology and mor-
phology was unexpected. However, it
had previously been shown that in
some developmental processes, such
as motoneuron formation (Sharma et
al., 1998), Lhx4 is fully competent to
substitute for Lhx3, which suggested
that the same could apply to placental
development. This possibility was also
supported by the finding that on E18
Lhx4 is expressed in the spongiotro-
phoblast, that is, in the tissue layer
where high Lhx3 transcripts levels
were detected between E12 and E16.
While deletion of both LIM-3 factors
resulted in a mild placental pheno-
type, this was not fully penetrant and
in addition affected the labyrinth,
whereas both Lhx3 and Lhx4 are ex-
pressed mainly in the junctional zone.
The ectopic phenotype may possibly
be explained by the fact that LHX3
and LHX4 are involved in transcrip-
tional regulation of several hormones,
such as glycoprotein -subunit, pro-
lactin, and follicle stimulating hor-
mone-	, which do not act in an auto-
crine manner (McGillivray et al.,
2005). It is difficult to explain the in-
complete penetrance, as it seems to be
established that no other LIM home-
odomain containing transcription fac-
tors can substitute for LHX3 and
LHX4 (Hobert and Westphal, 2000),
which excludes functional redun-
dancy. However, it is important to
note that several other LIM-homeobox
Fig. 3. Gnrhr expression level in Lhx3/; Lhx4/ and control placentas. A: Relative ratio of
Gnrhr/Tubb3 in Lhx3/; Lhx4/ and control placentas. B: Relative ratio of Gnrhr/Gapdh
Lhx3/; Lhx4/ and control placentas. Black column: gene expression level in Lhx3/;
Lhx4/ placentas. White column: gene expression level in control placentas. For detailed infor-
mation on mutant and control placentas, see Supplemental Table 2.
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genes are expressed in the placenta,
including Lhx5, which belongs to the
related LIN-11 group (Hobert and
Westphal, 2000). A simple explana-
tion could be that neither of the two
strains has been bred to full homozy-
gosity for a B6 background, so there is
the possibility that genetic heteroge-
neity underlies the incomplete pen-
etrance. Alternatively, it has been
shown that co-expression of Lhx3,
Nr5a1 (steroidogenic factor 1), and the
LIM-homeodomain containing tran-
scription factor Isl1 enhances expres-
sion of Gnrhr expression in mouse go-
nadotrope 	T3-1 and L	T2 cells
(Granger et al., 2006). In non-gonado-
trope COS cells, which normally do
not express Gnrhr, co-expression of
these expression factors is also compe-
tent to induce Gnrhr and interestingly
Nr5a1 and Isl1 alone induce expres-
sion, albeit at lower levels than when
Lhx3 was cotransfected. Co-expres-
sion of either Lhx5 or Lhx9 did not
increase Gnrhr activation above that
produced by Nr5a1 and Isl1 (Granger
et al., 2006). Performance of Lhx4 was
not tested in that study. Thus the pos-
sibility remains that in the mouse pla-
centa deletion of Lhx3 and Lhx4 can
be rescued to some degree by expres-
sion of Nr5a1 and Isl1, or Isl2, which
is also competent to induce Gnrhr
(Granger et al., 2006). However, to the
best of our knowledge it is not known
if these genes are expressed in the
mouse placenta. In addition, it is not
clear if the transcription factors en-
coded by these genes are at all in-
volved in transcriptional regulation of
Gnrhr in the placenta (Cheng et al.,
2000). While we have analyzed only
some genes involved in the gonado-
trope pathway, as these are known to
be expressed in the mouse placenta
(Khodr and Siler-Khodr, 1980; Tan
and Rousseau, 1982; Miyake et al.,
1982; Cheng et al., 2000), it is possible
that the inconsistent placental pheno-
type of Lhx3/; Lhx4/ double-
mutant conceptuses is in fact caused
by compromised regulation of other
target genes such as Foxl2 (Ellsworth
et al., 2006). However, the finding that
up-regulation of Gnrhr coincides with
phenotypical normality of Lhx3/;
Lhx4/ placentas may suggest that
the placental phenotypes were indeed
caused by altered GNRHR levels.
Over-expression of Lhx3/Lhx4 in Jeg3
trophoblast tumor cells or trophoblast
stem cells in vitro or in transgenic
mice in vivo could probably clarify the
functions of Lhx3 and Lhx4 in placen-
tal development, as over-expression
does not allow rescue through redun-
dancy (Heintz, 2001).
This study was initiated because of
our previous finding that Lhx3 is up-
regulated in enlarged IHPD placentas
(Singh et al., 2004). The fact that re-
duced Lhx3/Lhx4 expression has no
discernible effect on the phenotype of
AT24 placentas demonstrates that
over-expression of Lhx3 does not un-
derlie placental overgrowth. However,
as demonstrated previously (Singh et
al., 2004) Lhx3 expression in IHPD
placentas is ectopic and does not re-
flect the expression in normal placen-
tas, which shows that Lhx3 over-ex-
pression was not just a consequence of
increased spongiotrophoblast. Again,
over-expression of Lhx3 in tropho-
blasts in vitro or in vivo could possibly
provide information of the LIM-3





All experiments with mice were con-
ducted according to the guidelines is-
sued by Uppsala University. For iso-
lation of wild-type placentas, C57BL/6
(B6)  B6 matings were performed.
Pregnant females were killed by cer-
vical dislocation, with the day of vag-
inal plug being counted as day 1. Lhx3
and Lhx4 mutant mice (Sheng et al.,
1997, 1996) were kindly given to us by
Dr. Sally A. Camper, University of
Michigan. Both strains were propa-
gated in the original B6 strain back-
ground by mating heterozygous males
with wild-type females. However, nei-
ther strain was systematically back-
crossed to produce inbred B6 genetic
background. Fetuses and placentas
were weighed. Placentas were halved,
and one half was frozen on dry ice for
RNA extraction, while the other half
was fixed in Serra’s fixative overnight
at 4–8°C and later processed for par-
affin histology. Fetal tissue was frozen
prior to DNA extraction for genotyp-
ing. To generate Lhx3 and Lhx4 dou-
ble mutant mice, het  het matings
were performed between female
Lhx3/ and male Lhx4/ to pro-
duce double heterozygous mutant
mice. Subsequently, females and
males Lhx3/ Lhx4/ double het-
erozygous mice were mated to obtain
Lhx3/Lhx4 double mutants. Females
of the AT24 congenic strain (Hem-
berger et al., 1999; Elliott et al., 2001),
kindly provided by Dr. J. Forejt, Pra-
gue, were mated with Lhx3/;
Lhx4/ double heterozygous males
to generate heterozygous AT24/;
Lhx3/; Lhx4/ conceptuses.
AT24 contains a M. spretus-derived
proximal X chromosome. AT24 mice
exhibit a mild but consistent placental
hyperplasia that mimics IHPD not
only phenotypically (Hemberger et al.,
1999), but also in terms of gene
expression (Singh et al., 2005). To de-
termine the role of Gnrhr/ in pla-
cental development, Gnrhr/ het-
erozgous mice were mated to generate
Gnrhr/ and Gnrhr/ concep-
tuses for comparison (Pask et al.,
2005). Placentas were dissected from
the uteri of pregnant females on E18
and E19. The extraembryonic mem-
branes were removed and fetal and
placental weights were measured
prior to fixation of the placentas in 4%
paraformaldehyde.
Placental sections were phenotypi-
cally assessed independently by at
least three investigators who were not




Isolectin B4 (Vector Labs) and anti-
human alpha smooth muscle actin
(aSMA; Dako) staining and histology
were performed as described before
(Singh et al., 2007). Semiquantitative
morphometry was performed on
isolectin B4 stained sections as de-
scribed by Salas et al. (2004) using
Adobe PhotoshopCS. Values from two
randomly selected sections each from
two placentas of each genotype were
averaged. Sections near the placental
midline were used to exclude shifting
of placental compartments in lateral
sections. The area occupied by the cho-
rionic plate was excluded.
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mRNA In Situ Hybridization
Radioactive and non-radioactive in
situ hybridizations were performed as
described previously (Meunier et al.,
2003; Anson-Cartwright et al., 2000).
As placental cell type–specific mark-
ers, Tpbpa (Lescisin et al., 1988),
Prl3d1 (Guillemot et al., 1994), Prl3b1
(Monkley et al., 1996), Eomes (Ciruna
and Rossant, 1999; Russ et al., 2000),
and Tfeb (Steingrimsson et al., 1998)
were applied. A linearized Lhx3 clone
(accession number: AI893926), de-
rived from the cDNA library described
in a previous study (Singh et al. 2004),
was used as in vitro transcription tem-
plate. The Lhx4 probe was generated
by RT-PCR. The purified PCR product
was cloned into pGEMT Easy vector
(Promega). Digoxigenin (Roche) la-
beled sense and antisense riboprobes
were synthesized by in vitro transcrip-
tion using SP6 or T7 RNA poly-
merases. Primers used to generate the










Genomic DNA was extracted from fe-
tal tissues by using the Promega Wiz-
ard genomic DNA extraction kit. To
genotype Lhx3 mutant mice, two dif-
ferent primer pairs were used in sep-
arate reactions. The wild-type allele
was amplified using the primers 5
-
GTG ACT GCC ATG CTG CTA GA-3

and 5
-GGA TCT CTG GAG TCC TGC
TG-3
, whereas the neomycin cassette
inserted in the knockout allele was
amplified using the primer pair
5
-CGG CAT CAG AGC AGA TTG
TA-3
 and 5
-GCT TCC TCT TGC AAA
ACC AC-3
. Reaction conditions were
94°C for 3 min (94°C for 35 sec, 56°C
for 30 sec, 72°C for 45 sec)  35, 72°C
for 7 min, for the wild-type allele and
94°C for 3 min (94°C for 30 sec, 59°C
for 35 sec, 72°C for 45 sec)  35, 72°C
for 7 min for the mutant allele. To
genotype Lhx4 mutant mice, multi-
plex primers 5
-CTC GGA AGC TCA
GCT CAC TGT CAC TAA CCC-3
, 5
-




ATC CGA CTG TGA CCA CAG CTT
GAA-3
 were used. Reaction condi-
tions were 94°C for 3 min (94°C for 35
sec, 61°C for 30 sec, 72°C for 45 sec) 
35 cycles, 72°C for 5 min. Fetal sex
was determined by a Y chromosome–
specific PCR using the primer pair 5
-
CAT TTA TGG TGT GGT CCC
GTG-3
 and 5
-GTG TGC AGC TCT
ACT CCA G-3
. Conditions of the re-
action were 94°C for 3 min (94°C for
30 sec, 60°C for 30 sec, 72°C for 40
sec)  35, 72°C for 7 min. All genotyp-
ing PCRs were performed in PTC-100
PCR machines (MJ Research, Water-
town, MA). PCR products were re-
solved on 1.5% agarose gels. The ge-
notype of Gnrhr mice was assessed as
previously described (Pask et al.,
2005). Exon 1 of the Gnrhr gene was
amplified by PCR using the following
primers: forward, 5
-CTC CAC TCT
TGA AGC CTG TCC-3
; reverse, 5
-
TCA CCA TGT TCA CAC AAA TTC-
3
. Subsequently, the PCR product
was digested with DdeI and resolved




RNA was extracted using Trizol (In-
vitrogen). RQ1 DNAse (Promega) was
used to treat RNA, which was then
reverse transcribed using M-MLV re-
verse transcriptase and random prim-
ers (Promega) as described earlier
(Singh et al., 2004). QuantiTect SYBR
green PCR mix (Qiagen) and Rotor-
Gene RG3000 (Corbett Research) was
used for qRT-PCRs and each sample
was analysed in duplicate. Melt curve
was analysed to ensure specificity of
the PCR. Delta-delta Ct method was
used for analysis and the ratio of gene
expression for each sample was calcu-
lated by normalizing the comparative
quantitation values to those of Gapdh
and Tubb3. Primer sequences used in




Total lipid was extracted and purified
from 8 fetuses and their placentas (for
detailed information see Suppl. Table
2), using methanol/chloroform reagent
according to a standardized protocol
(Bligh and Dyer, 1959; Wuhrer et al.,
2000). Lipids were treated with 500
ml of 1 M HCl and 10 M H2O in meth-
anol for 16 hr at 100°C according to
Gaver and Sweeley (1965). Fatty ac-
ids, released as their methyl esters,
were recovered by a 3-fold phase par-
tition using n-hexane. Fatty acid
methyl esters were analyzed by gas
chromatography/mass spectrometry
using a VF 5ms capillary column (60
m, 0.25-mm inner diameter, 0.1-mm
film thickness; Varian, Darmstadt
Germany) and 2.5 ml/min helium as
carrier gas. Temperature was main-
tained at 50°C for 2 min, raised to
130°C with 40°C/min, and to 300°C
with 6°C/min, and was finally main-
tained at 300°C for 5 min. Fatty acid
compounds were registered by mass
spectrometry in the positive ion mode
after chemical ionization with metha-
nol using an PolarisQ instrument
(ThermoQuest Analytical Systems).
Statistical Analysis
Statistical analysis was carried out by
t-test using GraphPad Prism 3.0 (San
Diego, CA). A value of P  0.05 was
considered significant. Data are pre-
sented as mean  SD.
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